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Background: Assessing trends in cancer provides a means
for gauging progress against the disease, estimating future
demands for care and treatment, and suggesting clues about
shifting causal factors that may account for the more recent
changes. Purpose: This study was designed to evaluate
trends in the major sites of cancer associated with high mor-
tality rates in 15 industrialized countries. To highlight dif-
ferences among regions, we grouped these countries into six
geographic areas: United States, Eastern Europe, Western
Europe, East Asia, Oceania, and Nordic countries. In addi-
tion, cancer mortality trends in these regions were compared
with incidence patterns in the United States. Methods: Data
provided by the World Health Organization were used to
evaluate age-specific mortality trends from 1969 through
1986 for lung, breast, prostate, stomach, and colorectal can-
cers and for all other sites considered as a group. We also as-
sembled and analyzed data from the Surveillance,
Epidemiology, and End Results (SEER) Program of the Na-
tional Cancer Institute for the same sites and age groups
from 1973 through 1986. Results: Over the period 1969
through 1986, recorded cancer mortality in persons aged 45
years and older in the six regions studied has increased for
lung, breast, and prostate cancers in most age groups, while
the decline in stomach cancer mortality is substantial. The
increase in lung cancer deaths in men aged 45-54 years has
slowed greatly or reversed in all areas except Eastern
Europe and East Asia. Trends for intestinal cancer vary by
age and region. For all other sites considered as a group, in-
creases have occurred for persons older than 64 years in
most regions. In Eastern Europe, there are disturbingly high
rates and rapid increases for several of the major forms of
cancer in persons aged 45-54 years. In general, trends for
cancer incidence in the United States parallel those for mor-
tality. For intestinal cancer, however, incidence has in-
creased while mortality has declined. Conclusions: The
trends we report cannot be explained solely by changes in
cigarette smoking or aging. Other causes of changes in can-
cer incidence and mortality need to be determined. Implica-
tions: The increasing and decreasing trends in mortality
from and incidence of cancer that we found are important
for health care planning and may also suggest opportunities
for research in cancer prevention. [J Natl Cancer Inst
84:313-320,1992]
Differences in patterns of disease between and within coun-
tries can provide important clues about changing causal factors.
Where changes occur over a relatively short time, they can sug-
gest hypotheses for vital research initiatives. This study exam-
ined shifts in patterns of cancer in a number of industrialized
countries as recently as 1986.
About one fifth of the 11 million deaths in the industrialized
world each year are attributable to cancer {12). We examined
the mix of increases and decreases in the major cancer sites in
15 countries for specific 10-year age groups. For ages 45-84
years, age-specific rates were used to facilitate the comparison
of trends among countries in the age group in which most cancer
occurs. In the countries we studied, about 5% of the total num-
ber of deaths from all cancers occurred in people less than 45
years of age, while about 60% occurred in those aged 65 years
and over.
We expanded on previous work that analyzed mortality and
incidence trends in the United States (3,4) and mortality trends
in several other industrialized countries (5-70) by identifying
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mortality trends from 1969 through 1986 in 15 countries for
which the World Health Organization (WHO) believes there are
data of good quality. To aid in the interpretation of the mortality
data, we also examined trends in rates of cancer incidence in the
United States for the same cancer sites as recently as 1986.
Methods
To facilitate international comparisons of cancer patterns, we
grouped countries geographically as follows: United States;
Western Europe (France, Federal Republic of Germany, Italy,
England, and Wales); Eastern Europe (former German Demo-
cratic Republic, Czechoslovakia, and Hungary); Nordic coun-
tries (Finland and Norway); East Asia (Hong Kong, Japan, and
Singapore); and Oceania (New Zealand and Australia). Such a
grouping of countries can obscure individual country patterns,
but it permits broad assessments of differences among geo-
graphic regions.
We have combined data for the region of East Asia from three
very different locations—the countries of Japan and Singapore
and the city of Hong Kong. These areas were combined because
their data are more reliable than data from other countries in the
region, although not necessarily representative of the entire re-
gion. We recognize that Asia includes a number of developing
countries such as China and India for which reliable mortality
statistics are not available for this time period.
To prevent country effects from dominating, we did not
weight the individual country rates by population. Instead, we
calculated an arithmetic average of age-specific rates for each
country within the region, using the technique of Lopez (7). We
also calculated age-adjusted rates standardized to the U.S. 1986
age distribution for ages 45-84 years.
For the period from 1969 through 1986, WHO provided an-
nual data on cancer deaths with corresponding population data
for the 15 countries. Annual age-specific mortality rates in all
these groupings of countries were calculated separately for the
most common cancer sites (lung, stomach, intestine, breast, and
prostate) and for all other sites as a group. Mortality rates for in-
testinal cancer were used in these analyses to ensure compara-
bility with national rates for colon cancer and rectal cancer. (The
contribution of cancer of the small intestine is a very minor part
of intestinal cancer.) There can be considerable age-related vari-
ations in the effects of cancer treatment, in incidence trends, and
in reliability of data, which tends to be poorer at older ages. Be-
cause of these age-specific effects, we examined age-specific
rates in 10-year intervals for subjects 45-84 years of age.
Using data from the U.S. Surveillance, Epidemiology, and
End Results (SEER) Program, we derived annual age-specific
incidence rates for the same cancer sites from 1973 through
1986. To calculate the average yearly rate changes, simple nor-
mal theory linear regression analysis was applied to the ob-
served rates. Tables 1-6 report the yearly changes in each region
as a percentage of the 1986 observed rate. For changes in the
SEER incidence rates, we also report statistical significance in
the linear regression at the P<.0l level. (Significance levels
were not given for the regions because of the complexity of the
combined country data used to produce the regional rates.)
Results
Stomach Cancer Mortality
Table 1 shows a substantial annual decline in stomach cancer
mortality of about 2%-7% in each region and in each age group.
Fig. 1 shows a similar decline for each region. In the United
States, the rate of decline increased with increasing age, whereas
in East Asian males, the opposite is true. Elsewhere, there is no
clear age-related pattern.
Stomach cancer mortality rates are highest in East Asia, fol-
lowed very closely by Eastern Europe, and are lowest in the
United States. Rates are higher for males than for females in
every region, and the ratio of mortality for males versus females
is remarkably similar in each country and for each age group.
The fact that the rates in Nordic and Western European coun-
tries are two to three times higher than those in the United States
is of particular interest {11).
Lung Cancer Mortality
The increase in lung cancer deaths has been substantial for
most age groups (Table 2), but the increase has slowed greatly
or has reversed in males ages 45-54 years of age in all areas ex-
cept Eastern Europe and East Asia. Both the high mortality rate
and the rate of increase in Eastern European males aged 45-54
years particularly stand out. Rates for females of all ages are in-
creasing worldwide. Among females, the greatest percentage
and absolute increases in lung cancer occurred in the United
States. For women aged 75-84 years, rates in East Asia are
greater than those in the United States. Fig. 2 shows that the
rates for males in all countries are higher than those for females,
but the extent of this disparity varies greatly by region.
Prostate Cancer Mortality
Table 3 and Fig. 3 show that prostate cancer mortality is in-
creasing in all areas and at all ages except for ages 75-84 years
in Oceania. Although the absolute rates are lowest in East Asia,
the rates of increase for each age group are generally highest in
this region. The absolute rates at ages 65-74 and 75-84 years are
highest in the Nordic countries, with rates of increase at these
ages greater than for any region other than East Asia.
Breast Cancer Mortality
Table 3 and Fig. 4 indicate that breast cancer mortality is in-
creasing in all regions in most age groups—excepting the
youngest age group in the United States, the two youngest age
groups in the Nordic countries, and the oldest age group in
Oceania. Apart from the age group 75-84 years in Oceania, the
rates of increase are greater for people aged 65-84 years than at
younger ages. The greatest increases in breast cancer mortality
at young ages were in Eastern Europe. Although breast cancer is
increasing in all age groups, East Asian females continue to
have substantially lower rates than females in other regions.
Intestinal Cancer Mortality
The intestinal cancer rates shown in Table 4 and Fig. 5 pri-
marily represent colorectal cancers because of the low rates of
cancers of the small intestine. Intestinal cancer mortality is
greatest in Oceania and Eastern Europe in both males and fe-
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Table 1. Mortality rates per 100000 population for stomach cancer in 1986 and percent annual change from 1969 through 1986*
Age group, y
45-54
55-64
65-74
75-84
Totalt
45-54
55-64
65-74
75-84
Totalt
United States
6 (-2.3)
17 (-3.2)
36 (-3.6)
64 (-4.0)
22 (-3.5)
2 (-3.5)
7 (-3.6)
14(^.6)
31 (-4.8)
11 (-4.4)
Western Europe
13 (-4.6)
42 (-5.8)
112 (-4.4)
221 (-3.4)
67 (-4.4)
5 (-4.0)
16 (-6.1)
45 (-6.1)
112 (-5.4)
34 (-5.7)
Mortality rate (% annual change)
Eastern Europe
Males
20 (-4.1)
63 (-5.9)
157 (-5.4)
271 (-4.5)
92 (-5.1)
Females
9 (-4.5)
23 (-7.1)
70 (-6.8)
143 (-6.2)
48 (-6.5)
Nordic countries
12 (-6.1)
36 (-6.2)
92 (-6.7)
215 (-4.8)
59 (-5.9)
7 (-6.1)
16 (-5.3)
42 (-6.6)
105 (-6.6)
33 (-6.4)
East Asia
23 (-6.1)
73 (-5.6)
183 (-3.5)
291 (-1.0)
104 (-3.4)
13 (-4.9)
28 (-5.9)
65 (-5.5)
139 (-2.1)
49 (-4.1)
Oceania
8 (-2.7)
29 (-3.0)
65 (-4.1)
136 (-3.9)
41 (-3.7)
5 (-1.6)
8 (-6.5)
24 (-5.7)
63 (-5.0)
19 (-5.1)
•Percent annual change is based on the average annual change for the period 1969-1986 expressed as a percentage of the 1986 rate.
tAge-adjusted rate based on 1986 U.S. population.
males. Mortality is decreasing in all age groups in males and fe-
males for both the United States and Western Europe. The
opposite is occurring in Eastern Europe and East Asia, where
rates are increasing at a rate of l%-2% annually, with the mor-
tality rate in Eastern European men the highest of all regions.
Rates for males are uniformly higher than for females in each
age group and in each region.
Mortality for Other Cancers
Table 5 indicates that mortality attributable to cancers other
than stomach, lung, prostate, breast, and intestinal cancers has
increased in males over age 64 years in all regions and in
younger males, except for the United States and Nordic coun-
tries. For women, cancer mortality due to cancers in these other
sites has generally decreased in the younger age groups (45-64
years) and generally increased in older age groups (65-84
years). Fig. 6 indicates that the highest rates occur in Europe and
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Fig. 1. Stomach cancer in males (A) aged 45-84 years and females (B) aged 45-
84 years. Mortality data provided by WHO (1969-1986).
have increased in all regions for males in the age group 45-84
years.
U.S. Cancer Incidence
Annual rates of cancer incidence recorded in the U.S. SEER
Program increased for several of these same major sites of can-
cer over the period 1973 through 1986 (Table 6). Within our
broad groupings for age and type of cancer, only two groups
showed a statistically significant decrease in incidence: stomach
cancer and "other cancers" in females aged 45-64 years.
Discussion
Worldwide reductions in stomach cancer mortality are note-
worthy and encouraging. Dietary factors and improvements in
food storage and handling are thought to be major factors rele-
vant to this decline. Reduction in toxic methods of food preser-
vation, such as smoking and pickling, declining salt consump-
tion, widespread use of refrigeration, and increasing fruit and
vegetable consumption, may account for many of the changes in
stomach cancer incidence (72).
Changes in lung cancer mortality are largely attributable to
changes in smoking habits. Cigarette smoking is the single most
important preventable cause of cancer, accounting for about
30% of all cancer deaths. Worldwide, cigarette smoking causes
more than 3 million deaths annually (13). It is projected that in
about 40 years, smoking will claim more than 10 million lives
annually if current trends of increasing cigarette use continue
(Peto R, Lopez A: manuscript in preparation). Cigarette smok-
ing also contributes to cancers at a number of other sites, nota-
bly the oropharynx, larynx, bladder, esophagus, kidney, and
pancreas (14). While most of the changes in lung cancer mortal-
ity are due to changes in smoking habits, they may also, to a
smaller extent, reflect changes in air pollution, diet, and occupa-
tional factors (75). In East Asia, high rates of lung cancer may
be related to the use of smoky, carbonaceous fuels for domestic
cooking and heating (76).
The linear trend analysis we used does not reveal subtle time
changes and differences among countries. For instance, regard-
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Table 2. Mortality rates per 100 000 population for lung cancer in 1986 and percent annual change from 1969 through 1986*
Age group, y
45-54
55-64
65-74
75-84
Totalt
45-54
55-64
65-74
75-84
Totalt
United States
66(0.1)
219(0.9)
408(1.4)
546 (2.6)
245 (1.4)
34 (2.8)
92 (3.9)
148(4.4)
142 (3.8)
96 (3.9)
Western Europe
58 (0.6)
204(0.4)
395 (0.6)
544 (2.7)
235(1.0)
10(0.6)
38 (2.5)
69 (2.8)
82 (2.7)
44 (2.5)
Mortality rate (% annual change)
Eastern Europe
Males
99 (3.4)
273(1.6)
431 (0.0)
505(1.6)
275 (1.2)
Females
13(2.8)
31 (1.6)
54(1.3)
73 (0.4)
37(1.3)
Nordic countries
33 (-2.4)
153 (-0.8)
341 (0.3)
459 (2.4)
188 (0.4)
11 (3.0)
29 (3.5)
49 (3.3)
56 (2.2)
33 (3.0)
East Asia
42(1.4)
153(1.5)
331 (2.6)
517 (3.9)
195 (2.6)
14 (0.6)
50 (0.4)
141 (2.1)
201 (3.5)
84 (2.2)
Oceania
38 (-0.9)
159 (0.1)
368 (0.3)
538 (1.9)
206 (0.6)
16 (1.8)
52 (2.9)
95 (3.8)
107 (3.5)
60 (3.3)
*Percent annual change is based on the average annual change for the period 1969-1986 expressed as a percentage of the 1986 rate.
tAge-adjusted rate based on 1986 U.S. population.
ing lung cancer patterns, the net effect of combining England
and Wales with Western Europe is to obscure the downturn in
mortality in most age groups of males in England. Moreover,
the linear regression analyses in our tables cannot reveal other
recent changes, such as those that are occurring with decreases
in lung cancer in males in several countries. These changes are
readily apparent (Figs. 7 and 8) in the United States, England,
and Wales (6). Also, Fig. 9 illustrates the rapidly increasing
lung cancer mortality rates among U.S. women.
Prostate cancer deaths have increased in all regions, but they
show important variations. The rates in East Asia are from four
to six times lower than those in all the other regions but are in-
creasing rapidly. Nordic countries have the highest overall rates.
Dietary factors may be implicated, along with other environ-
mental exposures that could account for these substantial differ-
ences.
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Fig. 2. Lung cancer in males (A) aged 45-84 years and females (B) aged 45-84
years. Mortality data provided by WHO (1969-1986).
In the United States, the SEER data suggest that some of the
recorded increase in prostate cancer incidence may reflect im-
proved detection and increased access to health care. Gerber and
Chodak (17) correlate the increased use of transurethral resec-
tion of the prostate with the recorded increase in prostate cancer
incidence. While the incidence of prostate cancer has risen con-
siderably, mortality has increased at a much slower rate (4). It is
possible that the increased use of transurethral resection of the
prostate has influenced both recorded incidence and prostate
cancer mortality. Additional studies are needed to resolve this
matter because prostate cancer remains one of the major causes
of cancer mortality in men.
Breast cancer mortality in women at older ages has been in-
creasing in Western Europe, Eastern Europe, and East Asia
{18,19). This increase often has been attributed to changes in
risk factors for breast cancer, such as dietary fat consumption,
changes in parity distribution, and later age at birth of the first
child (2021). However, some analyses suggest that changes in
child-bearing patterns do not explain much of recent trends
(22,23).
Age-specific analyses of breast cancer mortality show that
different trends are occurring in different regions. For example,
breast cancer mortality is declining in premenopausal women in
the United States (24) and in Nordic countries, but not else-
where. The reasons for this decline are unclear, but they proba-
bly do not relate to detection of breast cancer through screening
programs because screening was not generally conducted on
women under the age of 50 years during the years 1973-1986
(25). Moreover, there is little evidence, at least in the first 10
years after initiation of screening (26), that screening reduces
breast cancer mortality in women aged 40-49 years.
One possible explanation for the downturn in breast cancer
mortality in younger women is the use of adjuvant chemother-
apy for breast cancer (27). Treatment may also shift premeno-
pausal breast cancer deaths to the postmenopausal group, but
this explanation does not account for the increases in breast can-
cer mortality in women over the age of 65 years. It may be that
increased mortality in older women reflects exposure to un-
known risk factors or promoters in the early part of this century.
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Table 3. Mortality rates per 100 000 population for prostate and breast cancers in 1986 and percent annual change from 1969 through 1986*
Cancer
Prostate
Breast
Age group, y
45-54
55-64
65-74
75-84
Totalt
45-54
55-64
65-74
75-84
Totalt
United States
3 (0.4)
25 (0.4)
111 (0.3)
322 (0.6)
68 (0.5)
45 (-1.0)
81 (0.2)
110 (0.7)
136 (0.6)
85 (0.3)
Western Europe
2 (0.8)
19(0.2)
102(1.0)
326 (0.8)
65 (0.9)
50 (0.5)
81 (0.9)
107(1.2)
149(1.1)
88(1.0)
Mortality rate (% annual change)
Eastern Europe
Males
2(2.1)
21 (0.3)
107(1.1)
289 (0.4)
63 (0.7)
Females
42 (0.9)
68(1.1)
95(1.6)
130(1.1)
76(1.2)
Nordic countries
2 (4.4)
25 (0.9)
132 (1.2)
421 (1.4)
84 (1.3)
37 (-0.3)
62 (-0.3)
85 (0.9)
135 (1.5)
71 (0.6)
East Asia
1(1.4)
5(2.1)
23(1.7)
72(2.9)
15(2.3)
22 (0.7)
31 (0.7)
38(1.3)
48(1.2)
33(1.0)
Oceania
3 (0.5)
22 (1.7)
116 (1.0)
355 (-0.3)
72 (0.4)
49 (0.4)
82 (0.5)
102 (0.7)
131 (-0.5)
84 (0.3)
•Percent annual change is based on the average annual change for the period 1969-1986 expressed as a percentage of the 1986 rate.
tAge-adjusted rate based on 1986 U.S. population.
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Fig. 3. Prostate cancer in males aged 45-84 years. Mortality data provided by
WHO (1969-1986).
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Fig. 4. Breast cancer in females aged 45-84 years. Mortality data provided by
WHO (1969-1986).
Mortality from intestinal cancer is declining at all ages and in
both sexes in the United States and in Western Europe. This de-
cline has also been noted in Canada for the last 10-15 years (20).
Some of the dietary and lifestyle modifications that are believed
to have contributed to the decline in cardiovascular disease mor-
tality in North America and Western Europe might also contrib-
ute to a decline in mortality from intestinal cancer in these
regions. In contrast, intestinal cancer mortality is increasing in
Eastern Europe and in East Asia.
In general, trends for cancer incidence in the United States
parallel those for mortality. However, in the United States, in-
testinal cancer incidence has increased while mortality has de-
clined. Cancer registries in the United States show an increasing
incidence of specific types of cancer in men and women aged
45-84 years (4). More complete registration or, possibly, inclu-
sion of more borderline cases and improved treatment may ac-
count for the differences in mortality rates.
The "other cancer" category in Table 5 includes several can-
cer sites but excludes most smoking-related cancers. For men
and women over age 64 years, worldwide increases are gener-
ally evident in these other forms of cancer. Site-specific analy-
ses are needed to identify what cancer types are contributing to
these trends.
Conclusions
When recorded deaths from lung cancer began to surge in the
1940s, a number of analysts asserted that this phenomenon was
due solely to improved diagnosis and detection of deaths pre-
viously attributed to tuberculosis (28,29). However, within a
few decades, the link of lung cancer with cigarette smoking was
firmly established. While diagnostic factors obviously have a
role in reported increases in incidence, the assumption should
not be made that they completely account for the broad interna-
tional trends in mortality that we have described.
In East Asia and Eastern Europe, the nature of the trends must
be carefully appraised. In these regions, access to care, the qual-
ity of medical diagnosis, and the use of medical technology may
have recently shifted. Thus, it is distinctly possible that rela-
tively low mortality rates in these regions at the beginning of
our study time were due to under-ascertainment of the true rate.
Consequently, the relatively large increases in rates in East Asia
and Eastern Europe should be cautiously interpreted.
Nonetheless, the fact that similar trends are occurring for sev-
eral major sites of cancer throughout these regions is note-
worthy. The explanation for changes in cancer mortality in
developed countries in older age groups involves factors and ex-
posures that may have occurred many years ago (30\31).
Changes in mortality rates for lung cancer and for some of the
sites included in the grouping "other cancer" largely reflect
changes in cigarette smoking patterns. However, we have identi-
fied changes in the incidence and mortality rates for cancers at
other sites in the middle and older age groups throughout the
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Table 4. Mortality rates per 100 000 population for intestinal cancer* in 1986 and percent annual change from 1969 through 1986t
Age group, y
45-54
55-64
65-74
75-84
Total*
45-54
55-64
65-74
75-84
Total*
United States
16 (-0.8)
52 (-0.5)
123 (-0.4)
232 (-0.3)
75 (-0.4)
13 (-2.3)
36 (-1.7)
82 (-1.5)
158 (-1.1)
58 (-1.4)
Western Europe
15 (-0.3)
51 (-0.6)
125 (-0.6)
263 (-0.1)
78 (-0.4)
12 (-1.7)
35 (-1.4)
80 (-1.0)
170 (-1.2)
59 (-1.2)
Mortality rate (% annual change)
Eastern Europe
Males
25(1.9)
77(1.3)
183(1.8)
316(1.8)
109(1.7)
Females
17(1.2)
47 (0.7)
115(1.5)
212(1.3)
79(1.2)
Nordic countries
14(0.1)
43(1.1)
115(1.4)
224(1.1)
69(1.2)
13(0.0)
33(1.1)
81 (0.7)
163(0.0)
58 (0.4)
East Asia
17(2.1)
40(1.5)
112(1.8)
181(1.5)
64(1.7)
14(1.2)
34(2.1)
69 (2.3)
136(2.9)
51 (2.4)
Oceania
28 (1.2)
80 (1.4)
144 (0.4)
283 (0.2)
98 (0.7)
22 (0.5)
67 (0.4)
114 (-0.2)
223 (-0.8)
88 (-0.2)
•Small intestine, colon, and rectum.
tPercent annual change is based on the average annual change for the period 1969-1986 expressed as a percentage of the 1986 rate.
* Age-adjusted rate based on 1986 U.S. population.
-0.4
0 25 50 75 MO CS
1986 Rate Par 100,000
- 2 - 1 0 1 2 3
Estftiated Annual Percent Change
B
0 25 50 75 KB
1966 Rate Per 100,000
•Oi
- 3 - 2 - 1 0 1 2 3
Estfrtatod Annual Percent Change
0.9
0
A
EastAsa j |
Unted States •
Oceania •
Nordc C0LH&I03 W^
Western Europe •
Eastern Europe •
100 200 300 400
1966 Rate Par 100,000
• • •224
0 1 2
Estimated Annual Percent Change
B
W 200 300 400
1966 Rate Per 100.000
-1 0 1
Estt i laUxl Annual Percent Change
Fig. 5. Intestinal cancer in males (A) aged 45-84 years and females (B) aged 45- Fig. 6. Other cancers in males (A) aged 45-84 years and females (B) aged 45-84
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Table 5. Mortality rates per 100 000 from other cancers* in 1986 and percent annual change from 1969 through 1986t
Age group, y
45-54
55-64
65-74
75-84
Total*
45-54
55-64
65-74
75-84
Total*
United States
83 (-O.2)
217 (-0.1)
420 (0.2)
707 (0.9)
270 (0.3)
67 (-2.0)
162 (-0.6)
312 (0.1)
508 (0.5)
221 (-0.1)
Western Europe
113 (1.3)
288 (0.8)
554 (0.9)
920 (1.5)
357 (1.1)
70 (-2.2)
166 (-0.6)
338 (0.4)
598 (0.8)
243 (0.1)
Mortality rate (% annual change)
Eastern Europe
Males
124 (2.3)
273 (1.2)
491 (0.8)
693 (0.6)
317 (1.0)
Females
89 (-0.7)
198 (-0.2)
380 (0.2)
568 (-0.1)
265 (-0.1)
Nordic countries
63 (-1.1)
191 (-0.3)
393 (0.3)
730 (0.8)
251 (0.2)
63 (-2.1)
154 (-0.2)
309 (-0.3)
589 (0.4)
229 (-O.1)
East Asia
115 (0.2)
264 (0.3)
471 (0.5)
712 (1.6)
308 (0.7)
69 (-2.3)
140 (-1.0)
261 (0.6)
438 (1.4)
192 (0.2)
Oceania
78 (0.3)
204 (0.7)
459 (1.1)
726 (1.1)
275 (0.9)
59 (-1.7)
165 (0.1)
311 (0.7)
540 (0.7)
224 (0.4)
•All cancers other than cancers of the lung, breast, prostate, stomach, and intestine (small intestine, colon, and rectum).
tPercent annual change is based on the average annual change for the period 1969-1986 expressed as a percentage of the 1986 rate.
*Age-adjusted rate based on 1986 U.S. population.
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Table 6. U.S. cancer incidence rates per 100 000 population (SEER) for 1986 with yearly percent change based on 1973 through 1986*
Age group, y Lung
Cancer incidence rate (yearly % change): males
Prostate Intestines Stomach Other
45-54
55-64
65-74
75-84
Total
Age group, y
83 (-0.8t)
248 (1.2)
465 (1.2)
548 (1.7)
274 (1.1)
Lung
18 (2.0) 50(0.6t)
154 (2.5) 157 (1.4)
563 (2.4) 323 (0.8)
1009 (1.6) 563 (1.2)
293 (2.1) 202 (1.1)
Cancer incidence rate (yearly % change): females
10(-2.3t)
28 (-1.2)
62 (-l.lt)
99 (-2.9)
37 (-1.7)
200
425
772
1085
498
(0.7)
(0.9)
(0.7)
(0.9)
(0.8)
Breast Intestines Stomach Other
45-54
55-64
65-74
75-84
Total
49 (2.3)
127 (3.9)
196 (4.8)
169 (4.8)
127 (4.2)
201 (0.0t)
297 (1.4)
412 (2.0)
447 (1.8)
318 (1.4)
39 (-0.3t)
107 (0.2t)
225 (0.3t)
384 (1.1)
156 (0.5)
5
10
26
48
18
(-0.6t)
(_I.7|)
(-1.9)
(-1-7)
(-1-7)
185 (-1.9)
351 (-1.5)
561 (0.6)
714 (0.8)
406 (-O.2t)
*Percent annual change is based on the average annual change for the period 1973-1986 expressed as a percentage of the 1986 rate.
fThe trend is not significantly different from zero (/><.01).
T r
1985 1987
Age
Report Year
O 45-54 O 55-64 4 65-74 x 75-84 Age • 55-64 A 65-74 x 75-84
Fig. 7. Lung cancer (International Classification of Disease No. 162) age- Fig. 9. Lung cancer (International Classification of Disease No. 162) age-
specific death rates for males in the United States. specific death rates for females in the United States.
1969 1971 1973 1975 1977 1979 1981 1983 1985 19
Report Vear
Age o 45-54 D 55-64 a 65-74 x 75-84
Fig. 8. Lung cancer (International Classification of Disease No. 162) age-
specific death rates for males in England and Wales.
industrialized world that are not likely to be explained solely by
alterations in cigarette smoking patterns. The other causes of
changes in cancer incidence and mortality rates need to be deter-
mined. The trends of increasing and decreasing incidence and
mortality rates reported here have implications for health care
planning and may also suggest opportunities for research in can-
cer prevention.
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